Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases - Wikidata - wikimedia - TriplyDB

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

http://www.wikidata.org/entity/Q36747524

about

Oncolytic viruses as therapeutic cancer vaccines Oncolytic viruses as immunotherapy: progress and remaining challenges A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds Promising oncolytic agents for metastatic breast cancer treatment The evolution of poxvirus vaccines Trial Watch:: Oncolytic viruses for cancer therapy A multi-targeted approach to suppress tumor-promoting inflammation Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism Effect of CXCL12/CXCR4 signaling on neuropathic pain after chronic compression of dorsal root ganglion The role of chemokines in breast cancer pathology and its possible use as therapeutic targets Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissue.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Risk of breast cancer with CXCR4-using HIV defined by V3 loop sequencing Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis Oncolytic Poxviruses.Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis.G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.Targeting tumor vasculature through oncolytic virotherapy: recent advances.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Harnessing the immune system for the treatment of breast cancer.Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis The signaling pathway of stromal cell-derived factor-1 and its role in kidney diseases.Oncolytic viruses and their application to cancer immunotherapy Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.A Normalization-Free and Nonparametric Method Sharpens Large-Scale Transcriptome Analysis and Reveals Common Gene Alteration Patterns in Cancers.Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bone Regeneration and Osteosarcoma via Reduction of VEGF and SDF-1.Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition.Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.Oncolytic Immunotherapy for Treatment of Cancer.Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses.Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy.Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer.Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer.The effect and mechanism of CXCR4 silencing on metastasis suppression of human glioma U87 cell line.

P2860

Q21245758-B0B979D7-172D-4B32-85AE-4AA67BA8A9AB Q26745942-C4340B04-3E7C-4A26-9391-25401E22529C Q26752846-388D53D1-9098-4B22-B082-278CD85D0028 Q26799120-370BE6C7-4003-465B-8F3E-E248B9D954D6 Q26830620-F1AEF495-E038-411B-BC77-4B41966E69C8 Q26995905-3CE9C535-DDF1-4597-AB81-187A5B018EE7 Q27021951-771BCB52-2A97-46A2-85AB-AD7160B515B0 Q28393278-B6278A1E-B0A0-471C-8A81-630B66A7AF67 Q33821628-9A7969E2-0F70-48E1-969C-72A3BC80DE61 Q33913982-223761A9-A431-465B-AA94-25E9F94CCF4D Q33915985-AC41B754-2FD5-4846-B85B-BA1156B4DFBA Q34069862-61F3909C-B798-4DDC-A801-FA67196FB950 Q34100269-0954C103-53C2-4AA4-942B-23629DBF0268 Q34476278-4320307F-B248-4837-A13B-EFFCEB559B23 Q34674367-D7140B78-30B3-4DEE-A3F8-5A43E392BB2B Q35157433-309E41B8-1428-4D14-8DDF-40F0F97136F1 Q35234349-8A539260-78BB-4D0B-88CE-418DF3F81D60 Q35921899-5A92393A-33A0-4140-9784-9A88330F79C2 Q35980816-0D1BE578-4EF0-4501-946B-A1C481CD7997 Q35994548-EBC49C24-F6F4-4CBF-A7A1-5D3694FE95C9 Q37031932-52923AF5-C881-4AA9-8EAA-41376B1A9664 Q37079141-3BA4A889-7DE2-443E-B8EC-820E6145EC68 Q37476039-606D34D0-895B-4F89-AD07-313521F4B083 Q37502464-84E31068-25CE-4D48-A859-4BB2C2C1DC81 Q37547939-0EAF2606-2E16-4793-9225-24AD07B04223 Q38168568-DA1EAFAA-5535-4811-85A6-BE4F57A3B63F Q38207011-354F75EE-06EE-42B1-8BCB-42301523C9F1 Q38317180-F4C22A72-3635-497D-9318-38C6ABEA38A3 Q38472331-E38F03F8-029B-4F40-95E1-928F2EF1449F Q38616639-E86A587A-38D3-455B-9AAA-4AC191AC3BF2 Q38699675-C12D8178-D521-45B7-A751-673E97B090CB Q38736616-E80E3757-6158-44AD-93EA-FE51D64CBA8C Q38782304-05AC6A00-B913-453E-AB94-792700C5807A Q38808628-BE714242-CB7D-42F2-9A0D-740D727A52F0 Q38848223-C9167E12-8CA7-49E4-9549-347CF08F61DC Q38924539-7C61B137-1512-41AE-8608-BC6790FDA12A Q38924557-62B70984-8B8C-46F3-B5C9-5C63BA567618 Q38981802-F97D811E-278C-451B-8353-1C290C8E7976 Q38985441-863E0A66-CEC6-4EFE-B8CA-CE943E69027D Q39061535-7880C0C8-3A26-4AC5-8330-5A16963F21C4

P2860

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

http://www.wikidata.org/entity/Q36747524

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Targeting CXCL12/CXCR4 signali ...... ibits breast cancer metastases

@en

type

label

Targeting CXCL12/CXCR4 signali ...... ibits breast cancer metastases

@en

prefLabel

Targeting CXCL12/CXCR4 signali ...... ibits breast cancer metastases

@en

P1433

Q36747524-F8662993-6A1B-44DC-8C1D-1F7AD16041A6

P1476

Q36747524-DE6AA6DD-69A2-4611-8C14-5737FC931B9E

P2093

Q36747524-09DC48F4-2A38-45FD-9A1A-0C0EA08A6743

Q36747524-33E46297-E991-4BB7-B3CF-4FA3A1369A47

Q36747524-89FEABA7-17E5-4B6B-98BE-D85210963B1C

Q36747524-B340F693-AFCA-46FA-9227-0604A764DC81

Q36747524-E72004B2-25BC-489E-8FE4-4CE62C0F3943

P2860

Q36747524-00DCF165-CF75-422A-B5F1-B4D21C0DE3FC

Q36747524-064E323C-BBBB-42ED-922A-D2F3A24BE88E

Q36747524-08F00CFB-C5E2-409D-BCF2-93A801111BD2

Q36747524-0F5339C5-97BC-4284-BF0D-C7CA07FD7609

Q36747524-1632FF6B-0E6A-4D8F-B148-48411F673CC4

Q36747524-1D99CEAC-0468-48FD-B7D3-D46ED32236CB

Q36747524-201B6FFA-1AC9-49CF-B5AE-783A881BCFE6

Q36747524-2863523F-F892-4395-898C-442CD7BC1694

Q36747524-2A9F8EAE-5A8B-4ED9-A40D-5788DF371305

Q36747524-373CE140-76B8-459A-B442-337C10CF8469

P304

Q36747524-83A86D8C-C3D5-4445-9021-AB3B4FBDB882

P31

Q36747524-B004A5B7-15E6-4C2F-9190-7AFEE9F9006D

P356

Q36747524-9B1EC0A7-BEE4-4348-ABD4-CFD1FCDE7BA9

P407

Q36747524-5D9A3AD1-BB1C-4F5A-AC89-A702AC70726F

P433

Q36747524-502CA3F6-2859-47EA-8B5C-BA88E0212343

P478

Q36747524-1F5FA882-8672-424C-830C-4AC66D7393DB

P577

Q36747524-53957708-CD3E-4078-B334-AEF838B892E0

P5875

Q36747524-19566482-9F9D-47DB-A1BA-DD581F8116E8

P698

Q36747524-33A5B0F7-A6CD-41DE-A6A7-8A9621E8E6EC

P921

Q36747524-F4FFB881-C12F-4C7E-A175-D1E5E34D9D1B

P932

Q36747524-5999AEA6-2151-4820-9F64-10AD1909E8B0

P356

PNAS.1220580110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Targeting CXCL12/CXCR4 signali ...... ibits breast cancer metastases

@en

P2093

Danuta Kozbor

http://www.w3.org/2001/XMLSchema#string

Marcin P Komorowski

http://www.w3.org/2001/XMLSchema#string

Margaret Gil

http://www.w3.org/2001/XMLSchema#string

Mukund Seshadri

http://www.w3.org/2001/XMLSchema#string

Scott I Abrams

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily

The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.

INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS

Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

The Ki-67 protein: from the known and the unknown

CXCR4 regulates growth of both primary and metastatic breast cancer

P304

E1291-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1220580110

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236061649

http://www.w3.org/2001/XMLSchema#string

P698

23509246

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3619300

http://www.w3.org/2001/XMLSchema#string